Direxion Daily S&P Biotech Bull 3X Shares (LABU): Price and Financial Metrics ETF
LABU Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $94.24 | 52-week high | $176.99 |
| Prev. close | $89.79 | 52-week low | $80.41 |
| Day low | $88.40 | Volume | 1,304,100 |
| Day high | $96.11 | Avg. volume | 1,885,118 |
| 50-day MA | $119.88 | Dividend yield | 0.58% |
| 200-day MA | $120.34 |
LABU Stock Price Chart Interactive Chart >
Direxion Daily S&P Biotech Bull 3X Shares (LABU) ETF Bio
The investment objective of the Direxion Daily S&P Biotech Bull 3X ETF seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index.
LABU ETF Info
| Issuer | Direxion Investments |
| Expense Ratio | 1.01% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Portfolio-Multi Asset |
| Sector | Biotech |
| Assets Under Management (AUM) | 778.93K |
| Net Asset Value (NAV) | $89.80 |
| Options? | Yes |
| Total Holdings | 149 |
LABU Top Holdings
| Symbol | Company | % of Total |
| DREYFUS GOVT CASH MAN INS | 25.49% | |
| GOLDMAN FINL SQ TRSRY INST 506 | 8.23% | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 3.89% | |
| NTRA | NATERA INC | 2.72% |
| DREYFUS TRSRY SECURITIES CASH MGMT | 2.69% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.4% |
| GILD | GILEAD SCIENCES INC | 2.39% |
| UTHR | UNITED THERAPEUTICS CORP | 2.31% |
| INCY | INCYTE CORP | 2.3% |
| SRPT | SAREPTA THERAPEUTICS INC | 2.09% |
LABU Price Returns
| 1-mo | -11.74% |
| 3-mo | -32.80% |
| 6-mo | -20.00% |
| 1-year | -18.56% |
| 3-year | -88.24% |
| 5-year | -92.32% |
| YTD | -22.54% |
| 2023 | -12.63% |
| 2022 | -80.36% |
| 2021 | -64.15% |
| 2020 | 74.66% |
| 2019 | 75.50% |
LABU Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||